School of Medicine
Showing 1,541-1,550 of 5,036 Results
-
Mary Kane Goldstein
Professor of Health Policy, Emerita
Current Research and Scholarly InterestsHealth services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities
-
Andrea Goldstein-Piekarski
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
BioDr. Goldstein-Piekarski directs the Computational Psychiatry, Neuroscience, and Sleep Laboratory (CoPsyN Sleep Lab) as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and PI within the Sierra-Pacific Mental Illness Research, Education and Clinical Center (MIRECC) at the Palo Alto VA. She received her PhD in 2014 at the University of California, Berkeley where she studied the consequences of sleep on emotional brain function. She then completed a Postdoctoral fellowship at Stanford focusing on understanding the brain basis of anxiety and depression.
As the director of the CoPsyN Sleep Lab she is developing a translational, interdisciplinary research program that combines human neuroimaging, high-density EEG sleep recording, and computational modeling to understand the neural mechanisms through which sleep disruption contributes to affective disorders, particularly depression, across the lifespan. The ultimate goals of this research are to (1) develop mechanistically-informed interventions that directly target aspects of sleep and brain function to prevent and treat affective disorders and (2) identify novel biomarkers which can identify which individuals are most likely to experience improved mood following targeted sleep interventions.
This work is currently supported by The KLS Foundation, a R01 from National Institute of Mental Health, and a R61 from the National Institute of Mental Health. -
Pedro Martins Gomes de Oliveira, MD
Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)
BioDr. Gomes de Oliveira is an oral maxillofacial surgeon, head and neck surgeon, and sleep specialist with the Stanford Health Care Sleep Surgery Program. He is also a clinical assistant professor in the Department of Otolaryngology – Head and Neck Surgery, Division of Sleep Surgery at Stanford University School of Medicine.
Dr. Gomes de Oliveira specializes in orthognathic (jaw) and sleep surgery. He treats simple to complex cases of obstructive sleep apnea, creating personalized, effective care plans for each of his patients.
Dr. Gomes de Oliveira studies new treatments and best practices in jaw, sleep, and facial surgeries. He has analyzed psychiatric and cardiovascular outcomes in sleep surgery patients and researched sports-related facial fractures. Dr. Gomes de Oliveira has a background as a clinical and scientific researcher for the NOVA Clinical Research Unit in Lisbon, Portugal.
National and international peer-reviewed journals, including the Journal of Cranio-Maxillo-Facial Surgery, have published Dr. Gomes de Oliveira’s work. He has been invited to share his findings at national and global meetings, including for the American Academy of Otolaryngology and the European Association for Cranio Maxillo Facial Surgery (EACMFS).
Dr. Gomes de Oliveira is a member of EACMFS and the Spanish Society of Oral and Maxillofacial and Head and Neck Surgery. He is also a board member of the Portuguese Society of Maxillofacial Surgery. -
Natalia Gomez-Ospina
Assistant Professor of Pediatrics (Genetics)
Current Research and Scholarly InterestsDr. Gomez-Ospina is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases.
1) Lysosomal storage diseases:
Her research program is on developing better therapies for a large class of neurodegenerative diseases in children known as lysosomal storage disorders. Her current focus is on developing genome editing of hematopoietic stem cells as a therapeutic approach for these diseases beginning with Mucopolysaccharidosis type 1 and Gaucher disease. She established a genetic approach where therapeutic proteins can be targeted to a single well-characterized place in the genome known as a safe harbor. This approach constitutes a flexible, “one size fits all” approach that is independent of specific genes and mutations. This strategy, in which the hematopoietic system is commandeered to express and deliver therapeutic proteins to the brain can potentially change the current approaches to treating childhood neurodegenerative diseases and pave the way for alternative therapies for adult neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease
2) Point of care ammonia testing
She also works in collaboration with other researchers at Stanford to develop point-of-care testing for serum ammonia levels. Such device will greatly improve the quality of life of children and families with metabolic disorders with hyperammonemia.
3) Gene discovery
Dr Gomez-Ospina lead a multi-institutional collaboration resulting in the discovery of a novel genetic cause of neonatal and infantile cholestatic liver disease. She collaborated in the description of two novel neurologic syndromes caused by mutations in DYRK1 and CHD4.
For more information go to our website:
https://www.gomezospina.com/
